Sort
39,280 grants matching “leukemia”
Functional Analysis of the Human Leukemia Gene E2A-PBX1
$381,283University Of California San Diego · R01 · FY2003 · CA
The influence of proteostasis loss in aging hematopoietic stem cells on leukemia initiation
$381,271Robert A.j. Signer · University Of California, San Diego · U01 · FY2021 · CA
Topology of Cancer Evolution and Heterogeneity
$381,270Raul Rabadan · Columbia University Health Sciences · U54 · FY2020 · CA
ROLE OF TLR2 IN REGULATING NORMAL AND PREMALIGNANT HEMATOPOIETIC STEM CELLS
$381,250Laura G. Schuettpelz · Washington University · R01 · FY2019 · HL
RETINOIDS IN HEMATOPOIESIS
$381,250John S Welch · Washington University · R01 · FY2019 · HL
TEMPORAL CHANGES IN MECHANISMS OF HSC SELF-RENEWAL AND MYELOID LEUKEMOGENESIS
$381,250Jeffrey Alan Magee · Washington University · R01 · FY2020 · HL
TEMPORAL CHANGES IN MECHANISMS OF HSC SELF-RENEWAL AND MYELOID LEUKEMOGENESIS
$381,250Jeffrey Alan Magee · Washington University · R01 · FY2017 · HL
ROLE OF TLR2 IN REGULATING NORMAL AND PREMALIGNANT HEMATOPOIETIC STEM CELLS
$381,250Laura G. Schuettpelz · Washington University · R01 · FY2021 · HL
ROLE OF TLR2 IN REGULATING NORMAL AND PREMALIGNANT HEMATOPOIETIC STEM CELLS
$381,250Laura G. Schuettpelz · Washington University · R01 · FY2020 · HL
Role of FA proteins in hematopoiesis
$381,250Qishen Pang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2011 · HL
ROLE OF TLR2 IN REGULATING NORMAL AND PREMALIGNANT HEMATOPOIETIC STEM CELLS
$381,250Laura G. Schuettpelz · Washington University · R01 · FY2018 · HL
ROLE OF TLR2 IN REGULATING NORMAL AND PREMALIGNANT HEMATOPOIETIC STEM CELLS
$381,250Laura G. Schuettpelz · Washington University · R01 · FY2017 · HL
TEMPORAL CHANGES IN MECHANISMS OF HSC SELF-RENEWAL AND MYELOID LEUKEMOGENESIS
$381,250Jeffrey Alan Magee · Washington University · R01 · FY2021 · HL
RETINOIDS IN HEMATOPOIESIS
$381,250John S Welch · Washington University · R01 · FY2020 · HL
RETINOIDS IN HEMATOPOIESIS
$381,250John S Welch · Washington University · R01 · FY2017 · HL
Molecular Immunology of Minor Histocompatibility Antigen
$381,250Sebastian Joyce · Vanderbilt University · R01 · FY2006 · HL
Decoding the Heterogeneity in Chemo-Immunomodulation to Unlock the Potential of Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer
$381,250Mohammed Olusoji Gbadamosi · University Of Florida · DP5 · FY2023 · OD
Tcf/Lef-b-catenin in T cell identity and cancer
$381,250Hai-Hui Xue · University Of Iowa · R01 · FY2017 · AI
Decoding the Heterogeneity in Chemo-Immunomodulation to Unlock the Potential of Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer
$381,250Mohammed Olusoji Gbadamosi · University Of Florida · DP5 · FY2025 · OD
Decoding the Heterogeneity in Chemo-Immunomodulation to Unlock the Potential of Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer
$381,250Mohammed Olusoji Gbadamosi · University Of Florida · DP5 · FY2024 · OD
TEMPORAL CHANGES IN MECHANISMS OF HSC SELF-RENEWAL AND MYELOID LEUKEMOGENESIS
$381,250Jeffrey Alan Magee · Washington University · R01 · FY2018 · HL
TEMPORAL CHANGES IN MECHANISMS OF HSC SELF-RENEWAL AND MYELOID LEUKEMOGENESIS
$381,250Jeffrey Alan Magee · Washington University · R01 · FY2019 · HL
RETINOIDS IN HEMATOPOIESIS
$381,250John S Welch · Washington University · R01 · FY2018 · HL
RETINOIDS IN HEMATOPOIESIS
$381,250John S Welch · Washington University · R01 · FY2016 · HL
CRLF2 signaling in B-cell acute lymphoblastic leukemia
$381,181David Marc Weinstock · Dana-Farber Cancer Inst · R01 · FY2019 · CA